Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Top Cited Papers
- 2 February 2015
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 112 (11), E1317-25
- https://doi.org/10.1073/pnas.1500076112
Abstract
The analysis of tumor-derived circulating cell-free DNA opens up new possibilities for performing liquid biopsies for the assessment of solid tumors. Although its clinical potential has been increasingly recognized, many aspects of the biological characteristics of tumor-derived cell-free DNA remain unclear. With respect to the size profile of such plasma DNA molecules, a number of studies reported the finding of increased integrity of tumor-derived plasma DNA, whereas others found evidence to suggest that plasma DNA molecules released by tumors might be shorter. Here, we performed a detailed analysis of the size profiles of plasma DNA in 90 patients with hepatocellular carcinoma, 67 with chronic hepatitis B, 36 with hepatitis B-associated cirrhosis, and 32 healthy controls. We used massively parallel sequencing to achieve plasma DNA size measurement at single-base resolution and in a genome-wide manner. Tumor-derived plasma DNA molecules were further identified with the use of chromosome arm-level z-score analysis (CAZA), which facilitated the studying of their specific size profiles. We showed that populations of aberrantly short and long DNA molecules existed in the plasma of patients with hepatocellular carcinoma. The short ones preferentially carried the tumor-associated copy number aberrations. We further showed that there were elevated amounts of plasma mitochondrial DNA in the plasma of hepatocellular carcinoma patients. Such molecules were much shorter than the nuclear DNA in plasma. These results have improved our understanding of the size profile of tumor-derived circulating cell-free DNA and might further enhance our ability to use plasma DNA as a molecular diagnostic tool.Keywords
Funding Information
- Hong Kong Research Grants Council Theme-Based Research Scheme (T12-404/11)
- S. K. Yee Foundation (Development of Medical Genomics)
- Innovation and Technology Commission, Hong Kong SAR Government (State Key Laboratory Programme)
- Li Ka Shing Foundation (Endowed Chair)
This publication has 53 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancerInternational Journal of Cancer, 2013
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome dataProceedings of the National Academy of Sciences of the United States of America, 2011
- Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsGenes, Chromosomes and Cancer, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- SOAP2: an improved ultrafast tool for short read alignmentBioinformatics, 2009
- Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1qInternational Journal of Cancer, 2008